Optical Assessment on Brain Death Via a Oxygen Supply Procedure

Sponsor
Chinese Academy of Medical Sciences (Other)
Overall Status
Unknown status
CT.gov ID
NCT03864887
Collaborator
(none)
80
1
10.6
7.5

Study Details

Study Description

Brief Summary

This study aims to evaluate brain death with optical probes. The changes of hemodynamic parameters including oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) were detected by near infrared spectroscopy probes attached on the forehead of patients. A multiple-phase protocol at varied fraction of inspired O2 were utilized during the assessment.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Oxygen supply of high-low-high procedure
  • Procedure: Oxygen supply of low-high-low procedure
  • Device: Optical monitor for hemodynamic parameter.

Detailed Description

Brain death is an irreversible loss of all brain functions, and the assessment is crucial for organ supply for transplantation. The noninvasive, sensitive, universally available and timely ancillary method to assess brain death has not been established. This study aims to evaluate brain death with optical probes. The changes of hemodynamic parameters including oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) were detected by near infrared spectroscopy probes attached on the forehead of patients. A multiple-phase protocol at varied fraction of inspired O2 were utilized during the assessment. The concentration changes ratios of oxyhemoglobin to deoxyhemoglobin (Δ[HbO2]/Δ[Hb]) in the cerebral cortex of brain-dead patients were significantly higher than those of healthy subjects.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
80 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Optical Assessment on Brain Death Via a Multiple-phase Protocol at Varied Fraction of Inspired O2
Actual Study Start Date :
Feb 11, 2019
Anticipated Primary Completion Date :
Aug 1, 2019
Anticipated Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Brain death patients for HLH Oxygen

Brain-dead patients were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of high-low-high procedure. During the procedures, the Δ[Hb] and Δ[HbO2] time courses were collected by Optical monitor for hemodynamic parameter.

Procedure: Oxygen supply of high-low-high procedure
The protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 60% FIO2 (phase I, high oxygen), half-hour measurement at 40% FIO2 (phase II, low oxygen) and half-hour measurement at 60% FIO2 (phase III, high oxygen).

Device: Optical monitor for hemodynamic parameter.
Near infrared spectroscopy probes of tow wavelengths were attached on the subjects' foreheat to detect the changes of hemodynamic parameters.

Brain death patients for LHL Oxygen

Brain-dead patients were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of low-high-low procedure. During the procedures, the Δ[Hb] and Δ[HbO2] time courses were collected by Optical monitor for hemodynamic parameter.

Procedure: Oxygen supply of low-high-low procedure
The protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 40% FIO2 (phase I, low oxygen), half-hour measurement at 60% FIO2 (phase II, high oxygen) and half-hour measurement at 40% FIO2 (phase III, low oxygen).

Device: Optical monitor for hemodynamic parameter.
Near infrared spectroscopy probes of tow wavelengths were attached on the subjects' foreheat to detect the changes of hemodynamic parameters.

Healthy people for HLH Oxygen

Healthy people were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of high-low-high procedure. During the procedures, the Δ[Hb] and Δ[HbO2] time courses were collected by Optical monitor for hemodynamic parameter.

Procedure: Oxygen supply of high-low-high procedure
The protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 60% FIO2 (phase I, high oxygen), half-hour measurement at 40% FIO2 (phase II, low oxygen) and half-hour measurement at 60% FIO2 (phase III, high oxygen).

Device: Optical monitor for hemodynamic parameter.
Near infrared spectroscopy probes of tow wavelengths were attached on the subjects' foreheat to detect the changes of hemodynamic parameters.

Healthy people for LHL Oxygen

Healthy people were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of low-high-low procedure. During the procedures, the Δ[Hb] and Δ[HbO2] time courses were collected by Optical monitor for hemodynamic parameter.

Procedure: Oxygen supply of low-high-low procedure
The protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 40% FIO2 (phase I, low oxygen), half-hour measurement at 60% FIO2 (phase II, high oxygen) and half-hour measurement at 40% FIO2 (phase III, low oxygen).

Device: Optical monitor for hemodynamic parameter.
Near infrared spectroscopy probes of tow wavelengths were attached on the subjects' foreheat to detect the changes of hemodynamic parameters.

Outcome Measures

Primary Outcome Measures

  1. Δ[HbO2] [1 day during the whole experiment]

    The changes of oxyhemoglobin concentrations in prefrontal cortex.

  2. Δ[Hb] [1 day during the whole experiment]

    The changes of deoxyhemoglobin concentrations in prefrontal cortex.

Secondary Outcome Measures

  1. Heart rate [1 day during the whole experiment]

    Heart rate of patient recorded by bed-side physiological monitor.

  2. Blood pressure [1 day during the whole experiment]

    Blood pressure of patient recorded by bed-side physiological monitor.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients who have had brain death or serious brain trauma.

  • Healthy people who are interested in optical assessment of hemodynamic parameters

Exclusion Criteria:
  • Patients who are in pregnancy or have plan to conception.

  • Patients who have vertebra surgery or have plan of surgery.

  • Patients who are inappropriate to join this trial judged by the radiologists or specialists.

  • AIDS, Active Hepatitis, Tuberculosis, Syphilis

  • Patients who regularly take anticoagulants, antiplatelet drugs

Contacts and Locations

Locations

Site City State Country Postal Code
1 NIRS assessment for brain death Tianjin Tianjin China 300000

Sponsors and Collaborators

  • Chinese Academy of Medical Sciences

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Ting Li, Professer, Chinese Academy of Medical Sciences
ClinicalTrials.gov Identifier:
NCT03864887
Other Study ID Numbers:
  • Brain Death of AMS
First Posted:
Mar 6, 2019
Last Update Posted:
Mar 6, 2019
Last Verified:
Mar 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ting Li, Professer, Chinese Academy of Medical Sciences
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 6, 2019